Jinlan Nie

Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Retraction notice to "Loss of Raf kinase inhibitor protein is associated with malignant progression in hepatic fibrosis" [Biomedicine & Pharmacotherapy 82 (2016) 669-676].

Retraction notice to "Loss of Raf kinase inhibitor protein is associated with malignant progression in hepatic fibrosis" [Biomedicine & Pharmacotherapy 82 (2016) 669-676].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 08, 2026

Retraction notice to Corrigendum to "Methyl helicterilate ameliorates alcohol-induced hepatic fibrosis by modulating TGF-β1/Smads pathway and mitochondria-dependent pathway" [Int. Immunopharmacol. 75 (2019) 105759].

Retraction notice to Corrigendum to "Methyl helicterilate ameliorates alcohol-induced hepatic fibrosis by modulating TGF-β1/Smads pathway and mitochondria-dependent pathway" [Int. Immunopharmacol. 75 (2019) 105759].

Journal: International immunopharmacology

Published: December 20, 2025

Retraction notice to "Didymin ameliorates hepatic injury through inhibition of MAPK and NF-κB pathways by up-regulating RKIP expression" [Int. Immunopharmacol. 42 (2017) 130-138].

Retraction notice to "Didymin ameliorates hepatic injury through inhibition of MAPK and NF-κB pathways by up-regulating RKIP expression" [Int. Immunopharmacol. 42 (2017) 130-138].

Journal: International immunopharmacology

Published: September 09, 2025

Retraction notice to "Methyl helicterilate ameliorates alcohol-induced hepatic fibrosis by modulating TGF-β1/Smads pathway and mitochondria-dependent pathway" [Int. Immunopharmacol. 75 (2019) 105759].

Retraction notice to "Methyl helicterilate ameliorates alcohol-induced hepatic fibrosis by modulating TGF-β1/Smads pathway and mitochondria-dependent pathway" [Int. Immunopharmacol. 75 (2019) 105759].

Journal: International immunopharmacology

Published: June 18, 2025

[Retracted] Inhibition of RKIP aggravates thioacetamide‑induced acute liver failure in mice.

[Retracted] Inhibition of RKIP aggravates thioacetamide‑induced acute liver failure in mice.

Journal: Experimental and therapeutic medicine

Published: May 25, 2023

Corrigendum to "Methyl helicterilate ameliorates alcohol-induced hepatic fibrosis by modulating TGF-β1/Smads pathway and mitochondria-dependent pathway" [Int. Immunopharmacol. 75 (2019) 105759].

Corrigendum to "Methyl helicterilate ameliorates alcohol-induced hepatic fibrosis by modulating TGF-β1/Smads pathway and mitochondria-dependent pathway" [Int. Immunopharmacol. 75 (2019) 105759].

Journal: International immunopharmacology

Published: January 08, 2021

Corrigendum to "Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells" [Chem. Biol. Interact. 261 (2017) 118-126].

Corrigendum to "Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells" [Chem. Biol. Interact. 261 (2017) 118-126].

Journal: Chemico-biological interactions

Published: December 19, 2020

Corrigendum to "Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways". [Int. Immunopharmacol. 66 (2019) 41-51].

Corrigendum to "Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways". [Int. Immunopharmacol. 66 (2019) 41-51].

Journal: International immunopharmacology

Published: December 22, 2019

Methyl helicterilate ameliorates alcohol-induced hepatic fibrosis by modulating TGF-β1/Smads pathway and mitochondria-dependent pathway.

Methyl helicterilate ameliorates alcohol-induced hepatic fibrosis by modulating TGF-β1/Smads pathway and mitochondria-dependent pathway.

Journal: International immunopharmacology

Published: April 17, 2019

Methyl helicterate inhibits hepatic stellate cell activation through downregulating the ERK1/2 signaling pathway.

Methyl helicterate inhibits hepatic stellate cell activation through downregulating the ERK1/2 signaling pathway.

Journal: Journal of cellular biochemistry

Published: November 12, 2018

Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways.

Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways.

Journal: International immunopharmacology

Published: August 23, 2018

Trolline Ameliorates Liver Fibrosis by Inhibiting the NF-κB Pathway, Promoting HSC Apoptosis and Suppressing Autophagy.

Trolline Ameliorates Liver Fibrosis by Inhibiting the NF-κB Pathway, Promoting HSC Apoptosis and Suppressing Autophagy.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: May 24, 2017

Showing 1-12 of 21

Last Updated: 09/26/2026